A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants

Clinical trial NCT07162116 · RECRUITING

Trial details

NCT number: NCT07162116
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia With FLT3/ITD Mutation

Start date: 2025-07-06
Primary completion: 2025-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.